Global Scientific Advisor - Doultegravir
ViiV Healthcare
Disclosure(s): GSK: Stocks/Bonds (Public Company); ViiV Healthcare: Employee
John Boulos, PharmD, BCIDP, AAHIVP, is a Global Scientific Advisor for Dolutegravir at ViiV Healthcare. He earned his Doctor of Pharmacy from the University of North Carolina Eshelman School of Pharmacy and a Bachelor of Science in Chemistry from the University of Florida. John Boulos completed PGY-1 and PGY-2 residencies in Pharmacy and Infectious Diseases at University of Florida Health Shands Hospital and The Johns Hopkins Hospital. Board-certified in Infectious Diseases Pharmacy and an American Academy of HIV Pharmacist, he has held leadership roles in real-world evidence and metabolic health working groups.